Evidence map›Paper›PMID 42361267›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

MAPK-activated protein kinase 2 orchestrates memory T-cell inflation in cytomegalovirus infection.

Eleni Panagioti, Xueyang Yu, Yi Wen Kong, Kristina Macakova, Noe B Mercado, Sean Edward Lawler, Michael B Yaffe, Charles H Cook

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Eleni PanagiotiDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.ORCID 0000-0002-7574-1378
Xueyang YuCenter for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Yi Wen KongCenter for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Kristina MacakovaDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Noe B MercadoDepartment of Pathology and Laboratory Medicine, Legorreta Cancer Center, Brown University, Providence, RI, United States.
Sean Edward LawlerDepartment of Pathology and Laboratory Medicine, Legorreta Cancer Center, Brown University, Providence, RI, United States.
Michael B YaffeDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Charles H CookDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Funding

Defining the role of cytomegalovirus in glioblastoma therapiesR01CA263324 · NCI · BROWN UNIVERSITY · PI CHARLES H COOK, Sean Edward Lawler · 2022 to 2026
$3.4M
NIH HHS R01CA263324
6 · The paper itself

Abstract

Memory T-cell inflation is a distinctive immunological phenomenon observed during persistent viral infections such as cytomegalovirus (CMV). Unlike conventional memory T-cell responses, which contract after infection resolution, a subset of CMV-specific T cells undergoes a progressive and sustained expansion, termed "inflation", which is thought to be critical for long-term immune surveillance. The molecular mechanisms that govern memory T-cell inflation remain incompletely understood, yet they are pivotal for understanding immune persistence and designing strategies against chronic viral infections. In this study, we investigated the role of MAPK-activated protein kinase 2 (MK2), a key downstream effector of p38 MAPK signaling, in regulating T-cell responses during murine CMV (MCMV) infection. Using MK2 knockout (MK2-KO) mice, we demonstrate that MK2 deficiency alters the dynamics of MCMV-specific CD8+ T-cell responses without impairing viral control or tissue replication. MK2 deficiency led to a reduction in noninflationary MCMV-specific CD8+ T cells during acute infection, followed by enhanced expansion of inflationary CD8+ T-cell subsets during latent infection. Furthermore, MK2-KO mice exhibited impaired effector differentiation, as evidenced by decreased expression of the terminal differentiation marker KLRG1 on MCMV-specific CD8+ T cells. Collectively, these findings identify MK2 as an important regulator of CD8+ T-cell magnitude, kinetics, and phenotype during both acute and latent MCMV infection. By demonstrating a role of MK2 in the regulation of memory T-cell inflation, this study provides new mechanistic insight into immune regulation with implications for vaccination, chronic infection, and immune aging.

Indexed as

CD8-Positive T-LymphocytesCytomegalovirus InfectionsHerpesviridae InfectionsImmunologic MemoryIntracellular Signaling Peptides and ProteinsMemory T CellsMuromegalovirusProtein Serine-Threonine KinasesAnimalsMAP-Kinase-Activated Kinase 2MiceMice, Inbred C57BLMice, KnockoutIntracellular Signaling Peptides and ProteinsMAP-Kinase-Activated Kinase 2Protein Serine-Threonine KinasesCD8+ T cellscytomegalovirusKLRG1memory inflationMK2

Identifiers

PMID42361267
PMCPMC13308694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.